day 1 agenda

VIROLOGY & INFECTIOUS DISEASES (WVID - 2025)
July 10-11, 2025 @ Vienna, Austria
Day-1 (July 10, 2025)
09:00-09:30                                            Registrations 
09:30-09:40                            Welcome Remarks by Moderator
Keynote Talks
Maja Mockenhaupt, University of Freiburg, Germany 09:40-10:10 Infections as possible trigger of epidermal necrolysis
Monica Lahra, NSW Health Pathology, Australia 10:10-10:40 Multidrug resistant N. gonorrhoeae
Ying Liao, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, China  10:40-11:10 Coronavirus Nucleocapsid Protein Enhances p-PKCα Binding to RACK1: Implications for Inhibition of Nucleocytoplasmic Trafficking and Suppression of the Innate Immune Response
Group Photo & Refreshment Break (11:10-11:30)
Technical Session-I 
Session Chairs: TBA
Jerina Jaho, University "Ismail Qemali" Vlore, Albania  11:30-11:50 Patients with HIV and Hepatitis B co-infection present special requirements for their management
Ximeng Han, Jenner Institute, University of oxford, UK 11:50-12:10 Preclinical Development of an Enhanced-Immunogenicity Pfs230-Pfs25 Malaria Transmission-Blocking Vaccine
Filomena Fiorito, University of Naples Federico II, Italy 12:10-12:30 TBA
Szu-Hao Kung, NATIONAL YANG MING CHIAO TUNG UNIVERSITY, Taiwan 12:30-12:50 Development of ionophore antibiotics as antiviral agents against enteroviruses and coronaviruses
Lunch Break @ Restaurant (12:50-14:00)
Technical Session-II
Session Chairs: TBA
TRAN ANH TU, CHANG GUNG UNIVERSITY, Taiwan  14:00-14:20 Precision Mapping of Influenza A Virus RNA Dynamics and Antiviral Responses Using an Advanced CRISPRCas12 Platform
Luca Del Sorbo, University of Naples Federico II, Italy 14:20-14:40 TBA
Hamsa Taher Tayeb, King Faisal Specialist Hospital & Research Center, Saudi Arabia 14:40-15:00 Implementation of Next Generation Sequencing (NGS) as a Diagnostic Tool in Infectious Diseases
Polona Kogovšek, National Institute of Biology, Slovenia 15:00-15:20 Evaluation of the antiviral activity of compounds using computational, bioassay, molecular biology and electron microscopy techniques
Bernard Efa, Alabama State University, USA 15:20-15:40 TBA
Muhammad Kashif, University of Strasbourg, France 15:40-16:00 The hiv-1 silencer bcl11b/ctip2 regulates the tlr3-mediated cellular response to viral infections in microglial cells
Refreshment Break (16:00-16:20)
Pannel Discussions

day 2 agenda

Day-2 (July 11, 2025) 
Keynote Talks
Abdolkarim Sheikhi, Queen’s University, Canada 09:30-10:00 The correlation between humoral immune responses and severity of clinical symptoms in COVID-19 patients
Edward A. Dominguez, Methodist Dallas Medical Center, USA 10:00-10:30 TBA
  10:30-11:00 Slot Available
Refreshment Break (11:00-11:20)
Technical Session-III
Session Chairs: TBA
Prachi Jhamb, University of Georgia, USA 11:20-11:40 Shedding light on development: Leveraging the new nightlights data to measure economic progress
  11:40-12:00 Slot Available
Lama Alsudias, King Saud University, Saudi Arabia 12:00-12:20 Using Natural Language Processing in Monitoring  Infectious Diseases in social media
Fatiya Khalifah Al-salmi, OMSB, Oman 12:20-12:40 The rate of bacterial/fungal co-infections and secondary infections in hospitalised COVID-19 infected patients at a tertiary care hospital in Oman
Hanjun ZHAO, Fudan University, China  12:40-13:00 Broad-spectrum antiviral peptide studies against respiratory viruses
Lunch Break @ Restaurant (13:00-14:00)
Session Chairs: TBA
Nikita Goswami, University of delhi south campus, India  14:00-14:20 Investigating the role of Mycobacterium tuberculosis transcriptional regulator VirS in acidic responses and identification of inhibitors against it
  14:20-14:40 Slot Available
WANG Xiankun, The University of Hong Kong, China 14:40-15:00 Human defensin derived peptide showing broad antiviral activity against human adenoviruses
S. J. D. O’Keefe, University of Pittsburgh, USA 15:00-15:20 Diet changes due to urbanization in South Africa are linked to microbiome and metabolome signatures of Westernization and colorectal cancer
  15:20-15:40 Slot Available
  15:40-16:00 Slot Available
Refreshment Break (16:00-16:20)
Award Ceremony 
Day 2 Concludes
NOTE: This is Tentative program and subject to change
For more information, Contact @ stella_gibbons@infectious-diseases.org

posters agenda

Will update soon...

Will be updated one month before to the conference dates...

Download